Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Sell
35
CDLX Quote, Financials, Valuation and Earnings
Last price:
$3.49
Seasonality move
:
-1.29%
Day range:
$3.55 - $3.83
52-week range:
$2.89 - $20.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.59x
P/B ratio:
2.78x
Volume:
1.1M
Avg. volume:
722.9K
1-year change:
-51.15%
Market cap:
$193.6M
Revenue:
$309.2M
EPS (TTM):
-$6.29
Analysts' Opinion
-
Consensus RatingCardlytics has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.40, Cardlytics has an estimated upside of 15.49% from its current price of $3.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $3.81.
Fair Value
-
According to the consensus of 5 analysts, Cardlytics has 15.49% upside to fair value with a price target of $4.40 per share.
CDLX vs. S&P 500
-
Over the past 5 trading days, Cardlytics has underperformed the S&P 500 by -0.57% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cardlytics does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cardlytics revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Cardlytics reported revenues of $67.1M.
Earnings Growth
-
Cardlytics has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cardlytics reported earnings per share of -$2.90.
Enterprise value:
339.9M
EV / Invested capital:
--
Price / LTM sales:
0.59x
EV / EBIT:
--
EV / Revenue:
1.16x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.39x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$127.7M
Return On Assets:
-50.62%
Net Income Margin (TTM):
-93.55%
Return On Equity:
-163.62%
Return On Invested Capital:
-67.37%
Operating Margin:
-25.13%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $302.5M | $302.5M | $293.5M | $79M | $67.1M | |
| Gross Profit | $113.7M | $124.3M | $127.7M | $35.8M | $28.6M | |
| Operating Income | -$118.4M | -$76.5M | -$63.1M | -$12.3M | -$16.9M | |
| EBITDA | -$74.9M | -$374.7M | -$238M | -$15.6M | -$135.3M | |
| Diluted EPS | -$3.51 | -$12.22 | -$6.29 | -$0.63 | -$2.90 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $353.9M | $335.5M | $249.1M | $205.6M | $183.3M | |
| Total Assets | $389.4M | $1.2B | $1.1B | $634.9M | $399.4M | |
| Current Liabilities | $58.3M | $274.5M | $254.9M | $179.5M | $155.9M | |
| Total Liabilities | $239.1M | $536M | $485.8M | $409.6M | $329.7M | |
| Total Equity | $150.4M | $688.6M | $580.5M | $225.3M | $69.7M | |
| Total Debt | $171.5M | $181.7M | $225.7M | $257.1M | $213.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$41.4M | -$16.2M | -$8.9M | $1.2M | $1.4M | |
| Cash From Investing | -$16M | -$11.8M | -$16M | -$3.1M | -$5.3M | |
| Cash From Financing | -$39.6M | -$20.3M | $1.7M | $21K | -$388K | |
| Free Cash Flow | -$55.1M | -$28.1M | -$27.4M | -$2M | -$3.9M | |
CDLX
Sector
Market Cap
$193.6M
$115.9M
Price % of 52-Week High
18.57%
68.02%
Dividend Yield
0%
0%
Shareholder Yield
-24.79%
3.52%
1-Year Price Total Return
-51.15%
-14.12%
Beta (5-Year)
1.529
0.695
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$3.80
200-day SMA
Sell
Level
$7.04
Bollinger Bands (100)
Buy
Level
3.41 - 4.11
Chaikin Money Flow
Buy
Level
31.5M
20-day SMA
Buy
Level
$3.79
Relative Strength Index (RSI14)
Sell
Level
49.99
ADX Line
Sell
Level
14.51
Williams %R
Neutral
Level
-26.087
50-day SMA
Sell
Level
$3.92
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
59.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.2999)
Sell
CA Score
(Annual)
Level (-2.2281)
Buy
Beneish M-Score
(Annual)
Level (-3.5889)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.6459)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
Stock Forecast FAQ
In the current month, CDLX has received 0 Buy ratings 5 Hold ratings, and 0 Sell ratings. The CDLX average analyst price target in the past 3 months is $4.40.
-
Where Will Cardlytics Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cardlytics share price will rise to $4.40 per share over the next 12 months.
-
What Do Analysts Say About Cardlytics?
Analysts are divided on their view about Cardlytics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardlytics is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is Cardlytics's Price Target?
The price target for Cardlytics over the next 1-year time period is forecast to be $4.40 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is CDLX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cardlytics is a Hold. 5 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CDLX?
You can purchase shares of Cardlytics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardlytics shares.
-
What Is The Cardlytics Share Price Today?
Cardlytics was last trading at $3.49 per share. This represents the most recent stock quote for Cardlytics. Yesterday, Cardlytics closed at $3.81 per share.
-
How To Buy Cardlytics Stock Online?
In order to purchase Cardlytics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
70
OKLO alert for Jan 6
Oklo [OKLO] is up 10.09% over the past day.
Sell
39
DOGZ alert for Jan 6
Dogness (International) [DOGZ] is up 3.39% over the past day.
Buy
66
DMRC alert for Jan 6
Digimarc [DMRC] is up 1.05% over the past day.
